Phase II trial of preoperative radiochemotherapy with concurrent bevacizumab, capecitabine and oxaliplatin in patients with locally advanced rectal cancer

by Dellas, Kathrin, Höhler, Thomas, Reese, Thomas, Würschmidt, Florian, Engel, Erik, Rödel, Claus, Wagner, Wolfgang, Richter, Michael, Arnold, Dirk, Dunst, Jürgen
Published 2013

Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastat...

by Marschner, Norbert, Arnold, Dirk, Engel, Erik, Hutzschenreuter, Ulrich, Rauh, Jacqueline, Freier, Werner, Hartmann, Holger, Frank, Melanie, Jänicke, Martina
Published 2015

Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancer

by Braig, Friederike, März, Manuela, Schieferdecker, Aneta, Schulte, Alexander, Voigt, Mareike, Stein, Alexander, Grob, Tobias, Alawi, Malik, Indenbirken, Daniela, Kriegs, Malte, Engel, Erik, Vanhoefer, Udo, Grundhoff, Adam, Loges, Sonja, Riecken, Kristoffer, Fehse, Boris, Bokemeyer, Carsten, Binder, Mascha
Published 2015